晨间信号Morning Signal
《今日营养师》 第28卷 第4期 · 2026年7月刊 · 中文解读

减肥药物后的体重维持新策略

Reframing Maintenance After Weight Loss Medications · Liz Weiss, MS, RDN, and Rosanne Rust, MS, RDN
约 24 分钟Features在小程序里点播,20 到 60 分钟做好
这篇讲什么
本文探讨了在停用GLP-1受体激动剂等减肥药物后,如何通过重置食欲、增强代谢灵活性和调整心态来维持体重,并提供了相应的饮食策略和食谱。
原文开头
Practical Strategies and Culinary Inspiration By Liz Weiss, MS, RDN, and Rosanne Rust, MS, RDN Glucagonlike peptide-1 receptor agonists (GLP-1 RAs) make it easier for some patients to lose weight. Endogenously produced GLP-1 helps regulate insulin secretion, slows stomach emptying, and influences signals to the brain that promote fullness. GLP-1 RA medications mimic these effects. Newer weight loss medications may also target GIP (glucose-dependent insulinotropic polypeptide), another hormone involved in blood sugar regulation and appetite control. Together, these pathways help patients feel less hungry while supporting metabolic regulation. While these medications are powerful tools, they do not replace foundational habits in the form of nutrition, physical activity, and other lifestyle-related behaviors impacting health. …
摘自《今日营养师》(Today's Dietitian)第28卷 第4期 · 2026年7月刊,Liz Weiss, MS, RDN, and Rosanne Rust, MS, RDN。仅引用开头一小段供了解文章,版权归原刊所有,全文请阅读原刊。
晨间信号小程序码
微信扫码,在小程序里听完整版
不用登录先听一篇 · 或在微信搜索小程序 晨间信号
同期其他文章